Eugenia uniflora leaves is employed in Nigerian traditional system of medicine for the treatment of cough, bronchitis, skin and wound infections. In this study, the in vitro antimicrobial activities of the methanolic extract, fractions and essential oils from the leaves of Eugenia uniflora were investigated on some multidrug resistant pathogens. The essential oil was obtained by hydrodistillation and its chemical profile was determined through GC and GC-MS analysis while the extracts were obtained by maceration with methanol followed by a mild liquid/liquid fractionation process. Antimicrobial activity of the test samples against Staphylococcus aureus, Klebsiella pnemoniae, Pseudomonas aeruginosa, Candida albicans and Trichophyton rubrum were determined using the agar well diffusion technique. The results showed that the GC-MS analysis of the essential oil yielded fifty one compounds; with benzofuran (17.23 %) as the major compound. Ethyl acetate extract exhibited largest inhibition on S. aureus, K. pnemoniae, P. aeruginosa, C. albicans and T. rubrum with diameter mean zones of inhibition (DMZI) 25.0 ± 1.0 mm, 23.0 ± 0.4 mm, 9.0 ± 0.3 mm, 22.7 ± 0.3 mm, and 21.0 ± 0.8 mm respectively. Hexane, methanol and aqueous extracts of E. uniflora gave DMZI range of 8.0-21.7 mm respectively on the tested isolates while essential oil exhibited DMZI range of 7.7-18.3 mm. The minimum inhibitory concentration (MIC) of the leaf test samples from E. uniflora ranged between 6.25-100 mg/ml, minimum bactericidal concentration (MBC) and minimum fungicidal concentration (MFC) ranged between 12.5-100 mg/ml. The death rate on the most susceptible bacterial isolate (Staphylococcus aureus) occurred at 45 min in 0.5 ml ethyl acetate (EtOAc) fraction. The mode of action of the EtOAc fraction on S. aureus cell was demonstrated to be by protein leakage. The results obtained in this study have implications in the use of E. uniflora leaves as an antimicrobial agent and hence may provide a drug lead for pharmaceutical preparations.
INTRODUCTION
The use of medicinal plants as a source of relief from illness is an art that is as old as mankind. In recent times, due to the increasing resistance of bacterial isolates for antibiotics, efforts to find alternative antimicrobial agents have intensified (Ahmed et al., 2012) . In the last four decades, quite a number of new antibiotics have been produced but the clinical efficacy of these existing antibiotics is being threatened by the emergence of multi drug-resistant pathogens (Khond et al., 2009; Awouafack et al., 2013; Bagla et al., 2014) . According to the World Health Organization (WHO) medicinal plants would be the best source to obtain a variety of drug compounds as over 80% of individuals from developed countries use traditional medicine which has compounds derived from medicinal plants (Dzoyem et al., 2014) . Therefore the need to investigate medicinal plants having ethnomedicinal values with a view of understanding their properties, safety and efficacy in pursuance of the search for new and potent antimicrobial compounds and fractions is of necessity.
Eugenia uniflora Linn (Myrtaceae) is a tropical and subtropical shrub widely distributed in America but distributed all over the world as an evergreen plant. Fresh and dried leaves of E. uniflora is reported in folk medicine for treating cough, bronchitis, diarrhoea, influenza, rheumatism, fevers, inflammatory and stomach diseases (Consolini and Sarubbio, 2002; Costa et al., 2009; Fiuza et al., 2009; Lago et al., 2010 and SouzaMoreira et al., 2010) . In Nigeria, E. uniflora leaves have been reported for antimalarial activities (Famuyiwa and Adebajo, 2012) . Pharmacological activities of the leaf extract of E. uniflora indicated inhibitory activity of the xanthine-oxidase enzyme through flavonoid action (Schmeda-Hirschmann et al., 1987) , a reduction in blood pressure measured by direct vasodilation and a slight diuretic effect (Consolini et al., 1999) . Extracts of E. uniflora leaves have been reported for volatile terpenoid oils, flavonoids, condensed and hydrolysable tannins, leucoanthocyanidins, steroids and or triterpenoids (Santos et al., 2004) . Lee et al., 1997 reported eugeniflorin D1 and eugeniflorin D2, as well as two hydrolysable macrocyclic tannins, in the leaf methanolic extract of Eugenia uniflora. Previous reports on the essential oils of Eugenia uniflora indicated presence of selina-1, 3, 7(11)-trien-8-one, germacrone, furanodiene and curzerene (Fiuza et al., 2009; Thambi et al., 2013) . Here we report the antimicrobial properties of the methanolic extract, three test fractions and essential oil from the fresh leaves of Eugenia uniflora on Klebsiella pnemoniae and Trichophyton rubrum for the first time.
MATERIALS AND METHODS Collection and authentication of plant material
Fresh leaves of E. uniflora were collected from Covenant University environment, Ota, Nigeria in June, 2015. The leaves were authenticated and identified at the Herbarium section of the Department of Botany, Obafemi Awolowo University, Ile-Ife. A voucher sample of the plant was deposited with accession number 17287.
Preparation of Eugenia uniflora extract and solvent fractions
Fresh leaves of E. uniflora were rinsed with distilled water and air dried at room temperature for ten days. The sample was ground into powder, using milling machine, and stored in an air-tight container for further use. Dried powdered leaves (740 g) was extracted by maceration in a jar using methanol (MeOH, 7.4L, 1:10, w/v) at ambient temperature for seven days with constant shaking. The extract was strained, filtered using Whatmann filter paper and then concentrated to dryness in 0 vacuo at 40 C. The MeOH crude extract was dissolved in distilled water and partitioned o separately using n-hexane (b.p, 65 C) and ethyl o acetate (b.p, 71 C) to yield hexane, ethyl acetate and aqueous fractions. The aqueous fraction was lyophilized, while the hexane and ethyl acetate fractions were evaporated to dryness. The dried extract and fractions were kept in amber glass bottles and stored in refrigerator prior to use.
Extraction of essential oil from Eugenia uniflora
Fresh leaves of Eugenia uniflora (554 g) was extracted for 4 h by hydrodistillation in a Clavenger-type apparatus. The essential oil obtained was separated from water and dried over anhydrous sodium sulphate. The extract was kept in sealed sample bottle and preserved in the refrigerator prior to analysis.
Gas Chromatography and Mass Spectrometry (GC-MS) Analysis
Essential oil obtained was analyzed using Agilent GC-7890A series Gas Chromatograph equipped with a flame ionization detection (FID) and DB-1 fused silica capillary column ( increased at the rate of 15 C/min to 250 C. Helium was used as the carrier gas at a flow rate of 1 ml/min, and the sample size was 0.1 µl, split ratio, 50:1. The percentage composition of the essential oil was determined with a Class-GC computer prog ramme and the relative percentages of the oil constituents were expressed as percentages by peak area normalization. The samples were diluted at a ratio 1:100, v/v in nhexane and 1.0 µl were injected manually in the split-less mode. Identification of essential oil components was based on the GC retention indexes calculated by using n-hydrocarbons and mass spectra by computerized matching of essential oil compounds with the National Institute of Standards and Technology (NIST), Timberland Regional Library (TRLIB) and Wiley libraries.
Micro-organisms:
The test organisms; Pseudomonas aeruginosa, Klebseilla pneumoniae, Staphylococcus aureus, Candida albicans and Trichophyton rubrum used in this study were from clinical isolates, obtained from the Laboratory stock culture of the Sacred Heart Hospital, Microbiology unit, Abeokuta, Ogun State, Nigeria. The organisms were sub--cultured on sterile agar slants and incubated at 37 °C for 48 h. and kept as stock cultures in the refrigerator. Biochemical and molecular analysis were carried out on the test organisms for re-confirmatory purposes.
Antimicrobial screening: The modified agar well diffusion method of Irobi et al., (1994) as previously described by Akinpelu and Onakoya (2006) was employed to determine the antimicrobial activities of the test samples leaf extracts at 100 mg/ml. The bacterial and fungal isolates were grown in Mueller Hinton broth and potato dextrose broth before use. Standardized 0.5 McFarland isolates (0.1 ml) were spread onto molten Mueller-Hinton agar plates for bacteria and Mueller-Hinton agar supplemented with 2 % glucose and 0.5 % methylene blue (MH-GMB) for yeast, while the same medium without methylene blue was used for mold (Fothergill, 2012) . Wells were bored into the agar medium using a sterile 6 mm cork borer after the medium have set. The wells were filled with 0.5 ml solution of the extracts and the plates were allowed to stand on the laboratory bench for 15 min before o incubating at 37 C for 24 h for bacteria and at room temperature for 72 h for fungi. The plates were observed for zones of inhibition. The effects of the extracts were compared with ciprofloxacin (standard antibiotic) and ketoconazole (standard antifungal) at a concentration of 1 mg/ml.
The minimum inhibitory concentrations (MIC) of each test sample was determined by measuring 0.5 ml of Brain Heart Infusion broth into ten rorhen test tubes. Solution of the test sample(s) was constituted in the broth to give two-fold serial dilutions. The final concentrations in each tube were 100, 50, 25, 12.5, 6.25, 3.125, 1.56, 0.78, 0.39 and 0.195 mg/ml. Standardized isolates suspension (0.1 ml) of each test organisms was then pipetted into the tubes and test carried out for each microorganisms and test sample. Controls were set up by dispensing 0.1 ml suspension of the test organisms into a tube containing 0.5 ml of the broth without the standard drugs/test samples. All the tubes were o incubated at 37 C for 24 h for bacterial isolates and 72 h for the fungal isolates. The MIC was taken as the least concentration of the test sample that inhibited the growth of the test organisms. Based on the MIC results, the concentrations of all the test sample that showed no visible growth of the tests isolates (tubes showing no turbidity) were sub-cultured onto blood agar plates for bacteria and yeast while potato dextrose agar plates for mould. Incubation of the plates was o carried out at 37 C for 24 h for bacteria and 72 h for fungi. T he minimum bactericidal concentration and minimum fungicidal concentration were taken as the least concentration of all the extracts that did not show any growth on the agar plates.
Data was replicated and analyzed using One-way Analysis of variance (ANOVA). Significant differences of triplicate mean values were determined at P < 0.05.
Determination of killing rate:
The rate of killing of the most susceptible bacterial isolate by the most active test sample, the ethyl acetate fraction was determined according to method described by Odenholt et al., (2001) . The bacterial suspension (S. aureus, 0.5 ml) was added to 4.5 ml of ethyl acetate fraction, suspension was mixed thoroughly after which 0.5 ml of the mixture was transferred into 4.5 ml peptone water broth containing 3 % Tween-80 and serially diluted up -5 to 10 in 4.5 ml sterile normal saline. The killing rate was determined over a period of 15 min for 2 h. The final dilution (0.5 ml) was transferred into labeled pre-sterilized molten Mueller-Hinton agar plates. The plates were incubated upside down at o 37 C for 72 h. Controls were set up alongside with the experiment using 0.5 ml of the test organism in 4.5 ml of normal saline and diluted out. Exactly 0.5 ml of the final dilution was spread on agar plates and incubated alongside with the experiment. The plates that showed no growth of the organism was taken as the time the antimicrobial agent killed the organism.
Determination of protein leakage assay
The mode of action of bacterial test cell by protein leakage assay was carried out following the method of Bradford (1976) , with slight modifications. Bacterial suspension (S. aureus, 0.5 ml) was added to 4.5 ml of the ethyl acetate extract. The suspension was thoroughly mixed, and centrifuged at 7000 rpm. 0.1 ml of the supernatant was added to 5 ml protein reagent (0.01 % (v/v) Coomassie brilliant blue, G-250, 4.7 % (v/v) ethanol and 8.5 % (v/v) phosphoric acid) in a tube and the contents were mixed thoroughly.
To 0.1 ml of bacterial suspension was added to 5 ml standard protein (randox protein kit) in another tube. Both tubes were incubated for 5 min o at 37 C. To 0.5 ml of both the standard and the test were transferred into 3 ml cuvette and the absorbance at 595 nm was measured. The amount of protein in the sample was determined using the formula:
Again, protein assays of the supernatant obtained were carried out using colorimeter at 260 nm and 280 nm. The concentration of protein present was determined using conversion factor Concentration (mg/ml) = (1. absorbance at 260 nm.
RESULTS AND DISCUSSION
The physical colour and yields of extracts, fractions and essential oil from E. uniflora are represented in table 1. Hydrodistillation of the fresh leaves from E. uniflora afforded a yellow viscous oil (0.4 %) with a pungent odor. The constituents analyzed by GC-MS revealed fiftyone compounds. Benzofuran (17.23 %) was the major compound in the essential oil from E. uniflora followed by 1-methyl-1-n-hexyloxy-1-silacyclopentane (10.23%), 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-cyclohexane (7.07 %), cryophyllene (6.31 %), gamma-elemene (5.51 %), beta-copaene (3.88 %) and globulol (2.03 %) ( Table 2) . Table 3 shows the susceptibility testing of E. uniflora leaf extracts on three bacterial strains (Staphylococcus aureus, Klebsiella pnemoniae and Pseudomonas aeruginosa) and two fungal strains (Candida albicans and Trichophyton rubrum). Though the effect of all the extracts on Pseudomonas aeruginosa was not significant (P >0.05), zones of inhibition were wider at 100 mg/ml with ethyl acetate extract, exhibiting more inhibition than 
Each value represent mean at ± S.D (n=3) at 100 mg/ml -No inhibition detected, P˂0.05 .5 -100 mg/ml, the MBC of the essential oils was 50 mg/ml, while MBC of extracts and essential oil of E.uniflora against samples used in this study. Generally, Eugenia genus has been reported for antimicrobial activities (Lago et al., 2010 ).
Among the microorganisms tested on the leaf extracts of E. uniflora, Staphylococcus aureus (Gram positive bacterium) was more susceptible to the extracts. This corroborates the report of Jigna and Sumitra (2006) , that plants extracts are more active against Gram positive bacteria than Gram negative bacteria.
Gas chromatography and mass spectrometry of
Pseudomonas aeruginosa was 100 mg/ml. In fungal isolates, the MFC ranged between 25-100 mg/ml in the extracts and essential oil from E.uniflora. Figure 1 shows the killing rate of ethyl acetate extract on Staphylococcus aureus. There were no surviving cell until 45 min.
Tab l e 5 : Mi n i mu m b a cteri ci d a l a n d m i n i mu m f u n g i ci d a l co n cen tra ti o n s o f E. uniflora leaf extracts
Extracts
Organisms/Concentration (mg/ ml) the essential oil from E. uniflora leaves revealed fifty-one compounds of which benzofuran (17.23 %) was the major compound, including cryophyllene, gamma-elemene and beta-copaene, as previously reported by Melo et al., 2007 , Lago et al., 2011 , Thambi et al., 2013 . Constituents of essential oil obtained in this study compared with those reported from E. uniflora in Brazil, Argentina and India (Melo et al., 2007; Lago et al., 2011 and Thambi et al., 2013 .
The bacterial and fungal strains (Staphylococcus aureus, Klebsiella pnemoniae, Pseudomonas aeruginosa, Candida albicans and Trichophyton rubrum) used in this study were susceptible to extracts obtained from E. uniflora leaves. Costa et al., 2010 reported that extracts from E. uniflora inhibited Candida albicans. However, in this report, antimicrobial activities of the leaves from E. uniflora on Klebsiella pnemoniae and Trichophyton rubrum are reported for the first time.
Diseases such as pneumonia, urinary and respiratory tract infections, and opportunistic infections are caused by Klebsiella species (Venkatesan et al., 2005 and De-Boer et al., 2005) . The alcoholic leaf extract of E. uniflora is reported in folk medicine for treating cough and bronchitis (Costa et al., 2009 and Lago et al., 2010) .
The low minimum inhibitory concentration observed for Staphylococcus aureus on the leaves from E. uniflora suggests high efficacy against this bacterium. Reports from this study agreed with traditional usage of E. uniflora to control infection varying from minor skin infections to severe life threatening infections such as septicemia, surgical wound infection and disseminated abscesses in all organs (Adegoke et al., 2010) .
The results of minimum inhibitory concentration, minimum bactericidal concentration and minimum fungicidal concentration showed that the leaf extracts from E. uniflora have bacteriostatic and bactericidal properties.
The death rate of the most susceptible microorganism (Staphylococcus aureus) was low with no surviving cells observed till 45 min/0.5 ml. However, the possible mode of action of ethyl acetate extract on Staphylococcus aureus by protein can be speculated to be due to disruption of cell membrane integrity, leading to eventual death of the bacterial cell tested.
CONCLUSION
With the appreciable level of inhibition exhibited by the leaf extracts of E. uniflora against the microorganisms used in this study, it suggests that this plant is a potential source of novel antimicrobial drug that can used for the management of cough, bronchitis, skin and wound infections. This is in line with folkloric practice.
